Simulations Plus Slashes Guidance Amid Biotech Spending Cuts, Analyst Expresses Doubt

benzinga.com/markets/earnings/25/06/45912081/simulations-plus-slashes-guidance-amid-biotech-spending-cuts-analyst-expresses-doubt

Simulations Plus Inc (NASDAQ:SLP) stock tanked after the company lowered its fiscal 2025 sales outlook.
The company expects third-quarter sales of $19 million-$20 million, much below the consensus of $22.78 million.
On Wednesday, the company cut its 2025 sales forecast to $76 million—$80…

This story appeared on benzinga.com, 2025-06-12 18:15:26.
The Entire Business World on a Single Page. Free to Use →